Serum Lipid Levels in Patients with Eating Disorders
Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Pr...
Saved in:
Published in | Internal Medicine Vol. 55; no. 14; pp. 1853 - 1857 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
The Japanese Society of Internal Medicine
01.01.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 0918-2918 1349-7235 1349-7235 |
DOI | 10.2169/internalmedicine.55.5632 |
Cover
Abstract | Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as ≥120 mg/dL and the non-HDL cholesterol risk as ≥150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases. |
---|---|
AbstractList | Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as ≥120 mg/dL and the non-HDL cholesterol risk as ≥150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases.Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as ≥120 mg/dL and the non-HDL cholesterol risk as ≥150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases. Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as greater than or equal to 120 mg/dL and the non-HDL cholesterol risk as greater than or equal to 150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases. Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as ≥120 mg/dL and the non-HDL cholesterol risk as ≥150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases. |
Author | Noma, Shun'ichi Teramukai, Satoshi Nakai, Yoshikatsu Fukusima, Mitsuo Taniguchi, Ataru |
Author_xml | – sequence: 1 fullname: Nakai, Yoshikatsu organization: Kyoto Institute of Health Sciences, Japan – sequence: 1 fullname: Teramukai, Satoshi organization: Department of Biostatistics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Japan – sequence: 1 fullname: Fukusima, Mitsuo organization: Division of Clinical Nutrition and Internal Medicine, Okayama Prefectural University, Japan – sequence: 1 fullname: Taniguchi, Ataru organization: Kyoto Preventive Medical Center, Japan – sequence: 1 fullname: Noma, Shun'ichi organization: Department of Psychiatry, School of Medicine, Kyoto University, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27432092$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkMtKxDAUhoMozkVfQbp00zHXpt0IouMFCgrqOqTpqRNp0zHJKL691eosxIWbczjw_f-Bb4Z2Xe8AoYTgBSVZcWJdBO9020FtjXWwEGIhMkZ30JQwXqSSMrGLprggeUqHMUGzEJ4xZrks6D6aUMkZxQWdIn4PftMlpV3bOinhFdqQWJfc6WjBxZC82bhKlsPlnpILG3pfgw8HaK_RbYDD7z1Hj5fLh_PrtLy9ujk_K1OTYR5TSgEEEZnBVVVpmesGGC4kE5wTKUhd8IpKWkvQjakN1ZjzmjU4k7XBJKsqNkfHY-_a9y8bCFF1NhhoW-2g3wRFciYZ45Tgf6BYyIxhwgf06BvdVINAtfa20_5d_UgZgHwEjO9D8NBsEYLVp3_1278SQn36H6Knv6LGxsFe76LXtv1Pwe1Y8ByifoLtZ-2jNS38GST8Kz42bEmz0l6BYx8CGq9W |
CitedBy_id | crossref_primary_10_1007_s10286_021_00836_z crossref_primary_10_12873_451valbuena crossref_primary_10_3390_nu12082331 crossref_primary_10_1016_j_physbeh_2024_114777 crossref_primary_10_3390_nu10121887 crossref_primary_10_1002_eat_24072 crossref_primary_10_1590_1518_8345_2567_3040 crossref_primary_10_3389_fnins_2021_682208 crossref_primary_10_1038_s41380_019_0573_3 crossref_primary_10_1016_j_jacl_2022_09_006 crossref_primary_10_1002_nbm_4469 crossref_primary_10_1007_s40519_023_01567_y crossref_primary_10_1002_erv_2833 crossref_primary_10_3390_ijms231810814 crossref_primary_10_1016_j_chc_2019_05_009 |
Cites_doi | 10.1210/jcem-38-2-325 10.1037/t07827-000 10.1002/1098-108X(199404)15:3<293::AID-EAT2260150315>3.0.CO;2-U 10.1079/BJN20041151 10.1001/jama.285.19.2486 10.1002/(SICI)1098-108X(199903)25:2<187::AID-EAT8>3.0.CO;2-9 10.1016/0167-5273(94)90270-4 10.1093/clinchem/18.6.499 10.1176/appi.books.9780890425596 10.1002/eat.20298 10.1016/j.psychres.2014.05.018 10.1097/01.crd.0000216745.96062.7c 10.1038/oby.2008.600 10.1002/(SICI)1098-108X(199805)23:4<425::AID-EAT10>3.0.CO;2-V 10.1007/s11739-014-1107-2 10.1507/endocrj1954.35.455 10.1016/j.physbeh.2011.08.014 10.1210/jcem-25-11-1520 10.1002/erv.2203 10.1016/0026-0495(78)90125-7 10.1016/j.jacl.2013.11.001 10.1097/01.yco.0000228759.95237.78 10.1002/eat.1087 10.1002/erv.2290 10.1016/j.psychres.2004.06.019 10.1002/eat.22389 10.1002/(SICI)1098-108X(199809)24:2<217::AID-EAT11>3.0.CO;2-W 10.1001/jama.2012.366 |
ContentType | Journal Article |
Copyright | 2016 by The Japanese Society of Internal Medicine |
Copyright_xml | – notice: 2016 by The Japanese Society of Internal Medicine |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 |
DOI | 10.2169/internalmedicine.55.5632 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1349-7235 |
EndPage | 1857 |
ExternalDocumentID | 27432092 10_2169_internalmedicine_55_5632 article_internalmedicine_55_14_55_55_5632_article_char_en |
Genre | Journal Article |
GroupedDBID | --- 29J 2WC 5GY ACPRK ADBBV ADRAZ AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CS3 DIK DU5 EBS EJD F5P HYE JSF JSH OK1 OVT P2P PGMZT RJT RNS RPM RZJ TR2 XSB .55 3O- 53G AAYXX CITATION EMOBN M48 TKC X7M 7.U CGR CUY CVF ECM EIF M~E NPM 7X8 7T5 H94 |
ID | FETCH-LOGICAL-c604t-22ee5156c0bbba78afe309735441751d94b272d7eafcdc2a044d3f067dc016bb3 |
ISSN | 0918-2918 1349-7235 |
IngestDate | Fri Jul 11 07:51:45 EDT 2025 Fri Jul 11 09:16:34 EDT 2025 Thu Jan 02 22:31:25 EST 2025 Tue Jul 01 01:40:02 EDT 2025 Thu Apr 24 23:05:06 EDT 2025 Wed Sep 03 06:29:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 14 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c604t-22ee5156c0bbba78afe309735441751d94b272d7eafcdc2a044d3f067dc016bb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/internalmedicine/55/14/55_55.5632/_article/-char/en |
PMID | 27432092 |
PQID | 1805763014 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1837334210 proquest_miscellaneous_1805763014 pubmed_primary_27432092 crossref_primary_10_2169_internalmedicine_55_5632 crossref_citationtrail_10_2169_internalmedicine_55_5632 jstage_primary_article_internalmedicine_55_14_55_55_5632_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-01-01 |
PublicationDateYYYYMMDD | 2016-01-01 |
PublicationDate_xml | – month: 01 year: 2016 text: 2016-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Internal Medicine |
PublicationTitleAlternate | Intern. Med. |
PublicationYear | 2016 |
Publisher | The Japanese Society of Internal Medicine |
Publisher_xml | – name: The Japanese Society of Internal Medicine |
References | 30. Kilgore M, Muntner P, Woolley JM, Sharma P, Bittner V, Rosenson RS. Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults. J Clin Lipidol 8: 86-93, 2014. 2. Nakai Y, Nin K, Noma S. Eating disorder symptoms among Japanese female students in 1982, 1992 and 2002. Psychiatr Res 219: 151-156, 2014. 9. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2012. Japan Atherosclerosis Society, Tokyo, Japan, 2012 (in Japanese). 28. Roehrig M, Masheb RM, White MA, Grillo CM. Dieting frequency in obese patients with binge eating disorder: Behavioral and metabolic correlates. Obesity 17: 689-697, 2009. 1. Nakai Y, Nin K, Noma S. Epidemiological data on eating disorders in Japan. In: New Developments in Anorexia Nervosa Research. Gramaglia C, Zeppegno P, Eds. Nova Science Publishers, INC, New York, 2014: 173-187. 19. Mordasini R, Klose G, Greten H. Secondary type II hyperlipoproteinemia in patients with anorexia nervosa. Metabolism 27: 71-79, 1978. 12. First M, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I disorders - Patient edition (SCID/P). In: Biometrics Research Department. New York State Psychiatric Institute, New York, 1995. 22. Case T, Lemieux S, Kennedy SH, Lewis GF. Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic. Int J Eat Disord 25: 187-193, 1999. 11. Ohwada R, Hotta M, Oikawa S, Takano K. Etiology of hypercholesterolemia in patients with anorexia nervosa. Int J Eat Disord 39: 598-601, 2006. 17. Klinefelter HF. Hypercholesterolemia in anorexia nervosa. J Clin Endocrinol 25: 1520-1521, 1965. 5. Nakai Y, Nin K, Noma S, Hamagaki S, Takagi R, Wonderlich SA. Outcome of eating disorders in a Japanese sample: A 4- to 9-year follow-up study. Eur Eat Disord Rev 22: 206-211, 2014. 25. Pauporte J, Walsh BT. Serum cholesterol in bulimia nervosa. Int J Eat Disord 30: 294-298, 2001. 10. Bannai C, Kuzuya N, Koide Y, et al. Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol Jpn 35: 455-462, 1988. 18. Nestel PJ. Cholesterol metabolism in anorexia nervosa and hypercholesterolemia. J Clin Endocrinol Metab 38: 325-328, 1974. 23. Vize CM, Coker S. Hypercholesterolemia in bulimia nervosa. Int J Eat Disord 15: 293-295, 1994. 21. Weinbrenner T, Zuger M, Jacoby GE, et al. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholestrolaemia. Br J Nutr 9: 959-969, 2004. 29. Carnier J, Sanches PL, da Silva PL, et al. Obese adolescents with eating disorders: analysis of metabolic and inflammatory status. Psychol Behav 105: 175-180, 2012. 4. Di Cola G, Jacoangeli F, Jacoangeli F, Lombardo M, Iellamo F. Cardiovascular disorders in anorexia nervosa and potential therapeutic targets. Intern Emerg Med 9: 717-721, 2014. 16. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2002. Japan Atherosclerosis Society, Tokyo, Japan, 2002 (in Japanese). 31. Garcia-Rubira JC, Hidalgo R, Gomez-Barrado JJ, Romero D, Cruz Fernandez JM. Anorexia nervosa and myocardial infarction. Int J Cardiol 45: 138-140, 1994. 8. Boekholdt SM, Arsenault BJ, Mora S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 307: 1302-1309, 2012. 13. Nakai Y, Fukushima M, Taniguchi A, Nin K, Teramukai S. Comparison of DSM-IV versus proposed DSM-5 diagnostic criteria for eating disorders in a Japanese sample. Eur Eat Disorders Rev 21: 8-14, 2012. 6. Casiero D, Frishman WH. Cardiovascular complications of eating disorders. Cardiol Rev 14: 227-231, 2006. 7. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001. 3. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 19: 389-394, 2006. 14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, Washington, DC, 2013. 24. Sullivan PF, Gendall KA, Bulik CM, Carter FA, Joyce PR. Elevated total cholesterol in bulimia nervosa. Int J Eat Disord 23: 425-432, 1998. 15. Friedewald WT. Estimation of the concentration of LDL cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972. 27. Mitchell JE, King WC, Pories W, et al. Binge eating disorder and medical comorbidities in bariatric surgery candidates. Int J Eat Disord 48: 471-476, 2015. 20. Mehler PS, Lezotte D, Eckel R. Lipid levels in anorexia nervosa. Int J Eat Disord 24: 217-221, 1998. 26. Monteleone P, Santonastaso P, Pannuto M, et al. Enhanced serum cholesterol and TG levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables. Psychiatry Res 134: 267-273, 2005. 22 23 24 25 26 27 28 29 (7) 2001; 285 30 31 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 8 9 20 21 |
References_xml | – reference: 20. Mehler PS, Lezotte D, Eckel R. Lipid levels in anorexia nervosa. Int J Eat Disord 24: 217-221, 1998. – reference: 1. Nakai Y, Nin K, Noma S. Epidemiological data on eating disorders in Japan. In: New Developments in Anorexia Nervosa Research. Gramaglia C, Zeppegno P, Eds. Nova Science Publishers, INC, New York, 2014: 173-187. – reference: 8. Boekholdt SM, Arsenault BJ, Mora S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 307: 1302-1309, 2012. – reference: 23. Vize CM, Coker S. Hypercholesterolemia in bulimia nervosa. Int J Eat Disord 15: 293-295, 1994. – reference: 17. Klinefelter HF. Hypercholesterolemia in anorexia nervosa. J Clin Endocrinol 25: 1520-1521, 1965. – reference: 2. Nakai Y, Nin K, Noma S. Eating disorder symptoms among Japanese female students in 1982, 1992 and 2002. Psychiatr Res 219: 151-156, 2014. – reference: 9. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2012. Japan Atherosclerosis Society, Tokyo, Japan, 2012 (in Japanese). – reference: 13. Nakai Y, Fukushima M, Taniguchi A, Nin K, Teramukai S. Comparison of DSM-IV versus proposed DSM-5 diagnostic criteria for eating disorders in a Japanese sample. Eur Eat Disorders Rev 21: 8-14, 2012. – reference: 12. First M, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I disorders - Patient edition (SCID/P). In: Biometrics Research Department. New York State Psychiatric Institute, New York, 1995. – reference: 4. Di Cola G, Jacoangeli F, Jacoangeli F, Lombardo M, Iellamo F. Cardiovascular disorders in anorexia nervosa and potential therapeutic targets. Intern Emerg Med 9: 717-721, 2014. – reference: 25. Pauporte J, Walsh BT. Serum cholesterol in bulimia nervosa. Int J Eat Disord 30: 294-298, 2001. – reference: 29. Carnier J, Sanches PL, da Silva PL, et al. Obese adolescents with eating disorders: analysis of metabolic and inflammatory status. Psychol Behav 105: 175-180, 2012. – reference: 14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, Washington, DC, 2013. – reference: 19. Mordasini R, Klose G, Greten H. Secondary type II hyperlipoproteinemia in patients with anorexia nervosa. Metabolism 27: 71-79, 1978. – reference: 7. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001. – reference: 11. Ohwada R, Hotta M, Oikawa S, Takano K. Etiology of hypercholesterolemia in patients with anorexia nervosa. Int J Eat Disord 39: 598-601, 2006. – reference: 5. Nakai Y, Nin K, Noma S, Hamagaki S, Takagi R, Wonderlich SA. Outcome of eating disorders in a Japanese sample: A 4- to 9-year follow-up study. Eur Eat Disord Rev 22: 206-211, 2014. – reference: 24. Sullivan PF, Gendall KA, Bulik CM, Carter FA, Joyce PR. Elevated total cholesterol in bulimia nervosa. Int J Eat Disord 23: 425-432, 1998. – reference: 3. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 19: 389-394, 2006. – reference: 30. Kilgore M, Muntner P, Woolley JM, Sharma P, Bittner V, Rosenson RS. Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults. J Clin Lipidol 8: 86-93, 2014. – reference: 18. Nestel PJ. Cholesterol metabolism in anorexia nervosa and hypercholesterolemia. J Clin Endocrinol Metab 38: 325-328, 1974. – reference: 28. Roehrig M, Masheb RM, White MA, Grillo CM. Dieting frequency in obese patients with binge eating disorder: Behavioral and metabolic correlates. Obesity 17: 689-697, 2009. – reference: 31. Garcia-Rubira JC, Hidalgo R, Gomez-Barrado JJ, Romero D, Cruz Fernandez JM. Anorexia nervosa and myocardial infarction. Int J Cardiol 45: 138-140, 1994. – reference: 16. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2002. Japan Atherosclerosis Society, Tokyo, Japan, 2002 (in Japanese). – reference: 26. Monteleone P, Santonastaso P, Pannuto M, et al. Enhanced serum cholesterol and TG levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables. Psychiatry Res 134: 267-273, 2005. – reference: 6. Casiero D, Frishman WH. Cardiovascular complications of eating disorders. Cardiol Rev 14: 227-231, 2006. – reference: 22. Case T, Lemieux S, Kennedy SH, Lewis GF. Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic. Int J Eat Disord 25: 187-193, 1999. – reference: 27. Mitchell JE, King WC, Pories W, et al. Binge eating disorder and medical comorbidities in bariatric surgery candidates. Int J Eat Disord 48: 471-476, 2015. – reference: 15. Friedewald WT. Estimation of the concentration of LDL cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972. – reference: 21. Weinbrenner T, Zuger M, Jacoby GE, et al. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholestrolaemia. Br J Nutr 9: 959-969, 2004. – reference: 10. Bannai C, Kuzuya N, Koide Y, et al. Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol Jpn 35: 455-462, 1988. – ident: 18 doi: 10.1210/jcem-38-2-325 – ident: 12 doi: 10.1037/t07827-000 – ident: 23 doi: 10.1002/1098-108X(199404)15:3<293::AID-EAT2260150315>3.0.CO;2-U – ident: 21 doi: 10.1079/BJN20041151 – volume: 285 start-page: 2486 issn: 0098-7484 year: 2001 ident: 7 publication-title: JAMA The Journal of the American Medical Association doi: 10.1001/jama.285.19.2486 – ident: 16 – ident: 22 doi: 10.1002/(SICI)1098-108X(199903)25:2<187::AID-EAT8>3.0.CO;2-9 – ident: 31 doi: 10.1016/0167-5273(94)90270-4 – ident: 15 doi: 10.1093/clinchem/18.6.499 – ident: 14 doi: 10.1176/appi.books.9780890425596 – ident: 11 doi: 10.1002/eat.20298 – ident: 9 – ident: 2 doi: 10.1016/j.psychres.2014.05.018 – ident: 6 doi: 10.1097/01.crd.0000216745.96062.7c – ident: 28 doi: 10.1038/oby.2008.600 – ident: 24 doi: 10.1002/(SICI)1098-108X(199805)23:4<425::AID-EAT10>3.0.CO;2-V – ident: 1 – ident: 4 doi: 10.1007/s11739-014-1107-2 – ident: 10 doi: 10.1507/endocrj1954.35.455 – ident: 29 doi: 10.1016/j.physbeh.2011.08.014 – ident: 17 doi: 10.1210/jcem-25-11-1520 – ident: 13 doi: 10.1002/erv.2203 – ident: 19 doi: 10.1016/0026-0495(78)90125-7 – ident: 30 doi: 10.1016/j.jacl.2013.11.001 – ident: 3 doi: 10.1097/01.yco.0000228759.95237.78 – ident: 25 doi: 10.1002/eat.1087 – ident: 5 doi: 10.1002/erv.2290 – ident: 26 doi: 10.1016/j.psychres.2004.06.019 – ident: 27 doi: 10.1002/eat.22389 – ident: 20 doi: 10.1002/(SICI)1098-108X(199809)24:2<217::AID-EAT11>3.0.CO;2-W – ident: 8 doi: 10.1001/jama.2012.366 |
SSID | ssj0038792 |
Score | 2.1819277 |
Snippet | Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a... |
SourceID | proquest pubmed crossref jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1853 |
SubjectTerms | Adolescent Adult Anorexia Nervosa - blood Bulimia - blood Bulimia Nervosa - blood Cardiovascular Diseases - blood Cardiovascular Diseases - epidemiology eating disorders Feeding and Eating Disorders - blood Feeding and Eating Disorders - epidemiology Feeding and Eating Disorders - physiopathology Female Humans Japan LDL cholesterol Lipids - blood Male non-HDL cholesterol Risk Factors Young Adult |
Title | Serum Lipid Levels in Patients with Eating Disorders |
URI | https://www.jstage.jst.go.jp/article/internalmedicine/55/14/55_55.5632/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/27432092 https://www.proquest.com/docview/1805763014 https://www.proquest.com/docview/1837334210 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Internal Medicine, 2016/07/15, Vol.55(14), pp.1853-1857 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgIMQL4nOULwWJtykldpykfUSoU4G2INFK4ylybGcN3RK0Jg_w13NnO1mGOlR4iaI0lzR35_PP5_sg5A2NNGWKx36Eo4lrWKdkIyy5H3OhYT5kLMcd3fkinq74x5Oot9FuskvqbCh_7cwr-R-pwjWQK2bJ_oNku4fCBTgH-cIRJAzHvWQMA705P8L20-pohtE_Jrj1iy2V6vLWJsIENrdVNrd9NOrcgWfdDjvizWW1-Wn8pxgy2nMULMTGtq7-Vm3XmHdkW6bY-Nhzg0G_rhvs0FLIddHpRbNptoX9eV4ATXXpKyiLU2zFYsxTLS6avgeC9j0QzpVIMZPD2VFtDWnIx37CbCmS1tLagrytRvGe3UTU0JuDsUDVLvvOaIzlUQvHnZY5wygaRrHzk14pqb34nB6vZrN0OTlZ3iS3WJLYvfwPn9rpOhwlpnN29xE23Avf9Pa691zBMLe_A4w_1devUAxSWd4n99wSw3tn9eUBuaHLh-TO3D39EeFGbTyjNp5VG68ovVZtPFQbz6qN16nNY7I6nizfT33XPMOXccBrnzGtAavGMsiyTCQjkesQSzOZnnMRVWOesYSpRItcKslEwLkKc8AuSoKIsyx8Qg7KqtRPiRdJjVAqUFJynmtsQECVEkrIgCmW0wFJWnak0lWWxwYnZymsMJGR6Z-MTKMoRUYOCO0of9jqKnvQTC3HOwo3_nZSUG7oLGl3J2Y0ggEZkNetzFKwqrhVJkpdNduUjmAdE6O74W_3hEkYckaDATm0Au_-EgNgzoIxe7YH9XNy93JUvSAH9UWjXwLSrbNXRlN_A_xurTI |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+Lipid+Levels+in+Patients+with+Eating+Disorders&rft.jtitle=Internal+medicine+%28Tokyo%2C+1992%29&rft.au=Nakai%2C+Yoshikatsu&rft.au=Noma%2C+Shun%27ichi&rft.au=Fukusima%2C+Mitsuo&rft.au=Taniguchi%2C+Ataru&rft.date=2016-01-01&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=55&rft.issue=14&rft.spage=1853&rft.epage=1857&rft_id=info:doi/10.2169%2Finternalmedicine.55.5632&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon |